Fingerprint
Dive into the research topics of 'A phase I/II study of the mTOR inhibitor everolimus in combination with hyperCVAD chemotherapy in patients with relapsed/refractory acute lymphoblastic leukemia'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically